Growth Metrics

Quest Diagnostics (DGX) Change in Cash (2016 - 2026)

Quest Diagnostics' Change in Cash history spans 18 years, with the latest figure at -$27.0 million for Q1 2026.

  • On a quarterly basis, Change in Cash rose 92.52% to -$27.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $205.0 million, a 171.68% increase, with the full-year FY2025 number at -$129.0 million, up 5.84% from a year prior.
  • Change in Cash hit -$27.0 million in Q1 2026 for Quest Diagnostics, down from -$12.0 million in the prior quarter.
  • Over the last five years, Change in Cash for DGX hit a ceiling of $543.0 million in Q4 2023 and a floor of -$385.0 million in Q4 2022.
  • Historically, Change in Cash has averaged -$28.2 million across 5 years, with a median of -$49.0 million in 2023.
  • Biggest five-year swings in Change in Cash: plummeted 322.22% in 2022 and later soared 2800.0% in 2024.
  • Tracing DGX's Change in Cash over 5 years: stood at -$385.0 million in 2022, then soared by 241.04% to $543.0 million in 2023, then plummeted by 139.59% to -$215.0 million in 2024, then surged by 94.42% to -$12.0 million in 2025, then tumbled by 125.0% to -$27.0 million in 2026.
  • Business Quant data shows Change in Cash for DGX at -$27.0 million in Q1 2026, -$12.0 million in Q4 2025, and $113.0 million in Q3 2025.